PT Royal Prima Tbk

Jakarta Stock Exchange PRIM.JK

PT Royal Prima Tbk EBITDA Margin for the year ending December 31, 2023: 19.75%

PT Royal Prima Tbk EBITDA Margin is 19.75% for the year ending December 31, 2023, a -22.83% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

PT Royal Prima Tbk EBITDA Margin for the year ending December 31, 2022 was 25.60%, a 9.19% change year over year.
PT Royal Prima Tbk EBITDA Margin for the year ending December 31, 2021 was 23.44%, a -17.97% change year over year.
PT Royal Prima Tbk EBITDA Margin for the year ending December 31, 2020 was 28.58%, a 68.77% change year over year.
PT Royal Prima Tbk EBITDA Margin for the year ending December 31, 2019 was 16.93%, a -10.63% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Jakarta Stock Exchange: PRIM.JK

PT Royal Prima Tbk

CEO	Dr. Tommy Leonard
IPO Date	May 17, 2018
Location	Indonesia
Headquarters	Gedung Grand Slipi Tower
Employees	784
Sector	Health Care
Industries Hospitals & Clinics

Description

PT Royal Prima Tbk provides hospital services in Indonesia. It operates its hospitals under the Royal Prima Medan and Royal Prima Jambi names. The company was founded in 2013 and is headquartered in Jakarta, Indonesia.

Key trends

Past 5 years